Trials / Unknown
UnknownNCT02937376
Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- University of Thessaly · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effects of N-acetyl Cystein (NAC) supplementation on redox status, physiological and biochemical parameters in G6PD deficient individuals after acute exercise.
Detailed description
In a randomized double-blind, crossover design, 12 adult volunteers with G6PD deficiency of both sexes will be supplemented with either 10 mg/kg of NAC (experimental condition - EC) or placebo (control condition - CC) every day for 4 weeks. Before intervention, all participants will be informed about the study protocol, fill a medical history questionnaire and sign an informed consent form. Moreover, measurements of anthropometric characteristics and physiological parameters, as well as a VO2max test will be performed. Participants will perform 4 trials of exercise (70% VO2max for 45min and 90% till exhaustion) before and after each condition. Blood samples will be collected before, immediately after and 1 hour after exercise. Moreover, measurements of anthropometric characteristics and physiological parameters will be performed before and after each condition. There will be a washout period of at 4 weeks between conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N-acetyl cystein | A trial of exercise before and after 4 weeks of N-acetyl cystein (NAC) supplementation. |
| OTHER | Placebo | A trial of exercise before and after 4 weeks of placebo administration. |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2023-06-01
- Completion
- 2023-11-01
- First posted
- 2016-10-18
- Last updated
- 2022-01-05
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT02937376. Inclusion in this directory is not an endorsement.